{"nct_id":"NCT02617589","title":"An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)","status":"COMPLETED","status_verified_date":"2023-03","start_date":"2016-03-01","start_date_type":"ACTUAL","primary_completion_date":"2019-01-17","primary_completion_date_type":"ACTUAL","completion_date":"2022-03-04","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["BMY"]}